Answers are grounded in this paper and cite their sources.
The BELIEVE study is the largest study to date demonstrating that retreatment with BV is an effective and well-tolerated option for patients with relapsed or refractory CD30-positive malignancies.
No takes yet. Share an insight, caveat, or question.
Sureda et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: